相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
Brian G. Till et al.
BLOOD (2008)
Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice
J. A. Westwood et al.
GENE THERAPY (2008)
The development of novel immunotherapeutic approaches in multiple myeloma
Stefan Peinert et al.
LEUKEMIA & LYMPHOMA (2008)
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen
Andrew M. Scott et al.
CLINICAL CANCER RESEARCH (2007)
BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells
Katharina M. Brauer et al.
CANCER RESEARCH (2007)
A comparison of allografting with autografting for newly diagnosed myeloma
Benedetto Bruno et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Redirecting T lymphocyte specificity by T cell receptor gene transfer - A new era for immunotherapy
Boris Engels et al.
MOLECULAR ASPECTS OF MEDICINE (2007)
Immunotherapy of multiple myeloma: the start of a long and tortuous journey
Simon J. Harrison et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using BLA-identical sibling donors in myelodysplastic syndromes
Rodrigo Martino et al.
BLOOD (2006)
Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice
JA Westwood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cytotoxic T lymphocyte therapy for Epstein-Barr virus Hodgkin's disease
CM Bollard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes
MWL Teng et al.
HUMAN GENE THERAPY (2004)
Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes
K Schag et al.
CLINICAL CANCER RESEARCH (2004)
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
SA Rosenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells
M Moeller et al.
CANCER GENE THERAPY (2004)
Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses
ZQ Liu et al.
HYBRIDOMA AND HYBRIDOMICS (2003)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation
NM Haynes et al.
JOURNAL OF IMMUNOLOGY (2002)
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors
NM Haynes et al.
BLOOD (2002)
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia
J Grenier et al.
EXPERIMENTAL HEMATOLOGY (2002)
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: Results of the UK MRC AML 10 trial
AK Burnett et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
C Guglielmi et al.
BLOOD (2002)
The fucosylated histo-blood group antigens H type 2 (blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes
Y Cao et al.
GLYCOBIOLOGY (2001)
Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector
BE Power et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
分享论文
